All Stories

  1. Epigallocatechin Gallate Modulates Microglia Phenotype to Suppress Pro-inflammatory Signalling Cues and Inhibit Phagocytosis
  2. Epigallocatechin Gallate Modulates Microglia Phenotype to Suppress Pro-Inflammatory Signalling Cues and Inhibit Phagocytosis
  3. Anionic lipid vesicles have differential effects on the aggregation of early onset-associated α-synuclein missense mutants
  4. Chromatin interaction maps identify Wnt responsive cis-regulatory elements coordinating Paupar-Pax6 expression in neuronal cells
  5. Library-Derived Peptide Aggregation Modulators of Parkinson’s Disease Early-Onset α-Synuclein Variants
  6. A Downsized and Optimised Intracellular Library-Derived Peptide Prevents Alpha-Synuclein Primary Nucleation and Toxicity Without Impacting Upon Lipid Binding
  7. Neuro-nutraceuticals: Natural products nourish the brain but be aware of contrary effects
  8. Oral (−)-Epicatechin Inhibits Progressive Tau Pathology in rTg4510 Mice Independent of Direct Actions at GSK3β
  9. Flavonoids as an Intervention for Alzheimer’s Disease: Progress and Hurdles Towards Defining a Mechanism of Action
  10. The Library Derived 4554W Peptide Inhibits Primary Nucleation of α-Synuclein
  11. The Bidirectional Relationship Between Sleep and Inflammation Links Traumatic Brain Injury and Alzheimer’s Disease
  12. A series of helical α-synuclein fibril polymorphs are populated in the presence of lipid vesicles
  13. Analysis of Protein Glycation Using Phenylboronate Acrylamide Gel Electrophoresis
  14. Excitation-Energy-Dependent Molecular Beacon Detects Early Stage Neurotoxic Aβ Aggregates in the Presence of Cortical Neurons
  15. Advanced Glycation End Products Modulate Amyloidogenic APP Processing and Tau Phosphorylation: A Mechanistic Link between Glycation and the Development of Alzheimer’s Disease
  16. Increased Foxo3a Nuclear Translocation and Activity is an Early Neuronal Response to βγ-Secretase-Mediated Processing of the Amyloid-β Protein Precursor: Utility of an AβPP-GAL4 Reporter Assay
  17. Structural evidence of quercetin multi-target bioactivity: A reverse virtual screening strategy
  18. Nutrition for the ageing brain: Towards evidence for an optimal diet
  19. Macrophage Migration Inhibitory Factor is subjected to glucose modification and oxidation in Alzheimer’s Disease
  20. Neuro-nutraceuticals: Further insights into their promise for brain health
  21. Neuro-nutraceuticals: The path to brain health via nourishment is not so distant
  22. Dietary (−)-epicatechin as a potent inhibitor of βγ-secretase amyloid precursor protein processing
  23. Decreased rabphilin 3A immunoreactivity in Alzheimer’s disease is associated with Aβ burden
  24. AMPA Receptor Activation Promotes Non-Amyloidogenic Amyloid Precursor Protein Processing and Suppresses Neuronal Amyloid-β Production
  25. Analysis of protein glycation using fluorescent phenylboronate gel electrophoresis
  26. Potential Neuroprotective Actions of Dietary Flavonoids
  27. Tau phosphorylation in human brain: relationship to behavioral disturbance in dementia
  28. Prion protein expression alters APP cleavage without interaction with BACE-1
  29. Neuroprotective effects of phenolic antioxidant tBHQ associate with inhibition of FoxO3a nuclear translocation and activity
  30. Pro-oxidant diet enhances β/γ secretase-mediated APP processing in APP/PS1 transgenic mice
  31. Neuroinflammation: Modulation by flavonoids and mechanisms of action
  32. Flavonoids, cognition, and dementia: Actions, mechanisms, and potential therapeutic utility for Alzheimer disease
  33. Synthesis, physical–chemical characterisation and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1H)-ones: Iron chelators with the potential for treating Alzheimer’s disease
  34. Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease
  35. Tumour necrosis factor alpha induces rapid reduction in AMPA receptor-mediated calcium entry in motor neurones by increasing cell surface expression of the GluR2 subunit: relevance to neurodegeneration
  36. Synaptic NMDA Receptor Activation Stimulates α-Secretase Amyloid Precursor Protein Processing and Inhibits Amyloid-β Production
  37. The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury
  38. Glial metabolism of quercetin reduces its neurotoxic potential
  39. Dietary flavonoid (−)epicatechin stimulates phosphatidylinositol 3‐kinase‐dependent anti‐oxidant response element activity and up‐regulates glutathione in cortical astrocytes
  40. Aβ1–42 modulation of Akt phosphorylation via α7 nAChR and NMDA receptors
  41. Neuroprotective effects of hesperetin in mouse primary neurones are independent of CREB activation
  42. Phosphatidylinositol 3-Kinase Is a Key Mediator of Central Sensitization in Painful Inflammatory Conditions
  43. Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY‐5Y cells
  44. Activation of pro-survival Akt and ERK1/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons
  45. CB2 cannabinoid receptors promote mouse neural stem cell proliferation
  46. Metals ions and neurodegeneration
  47. (‐)Epicatechin stimulates ERK‐dependent cyclic AMP response element activity and up‐regulates GluR2 in cortical neurons
  48. Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro
  49. Cyclin-dependent kinase 5, Munc18a and Munc18-interacting protein 1/X11α protein up-regulation in Alzheimer’s disease
  50. Activity‐dependent phosphorylation of Akt/PKB in adult DRG neurons
  51. Zinc–histidine complex protects cultured cortical neurons against oxidative stress-induced damage
  52. Flavonoids: antioxidants or signalling molecules?
  53. Inhibiting Src family tyrosine kinase activity blocks glutamate signalling to ERK1/2 and Akt/PKB but not JNK in cultured striatal neurones
  54. Expression of SOD1 G93A or wild‐type SOD1 in primary cultures of astrocytes down‐regulates the glutamate transporter GLT‐1: lack of involvement of oxidative stress
  55. Modulation of Pro-survival Akt/Protein Kinase B and ERK1/2 Signaling Cascades by Quercetin and Its in Vivo Metabolites Underlie Their Action on Neuronal Viability
  56. Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites
  57. The ‘glial’ glutamate transporter, EAAT2 (Glt‐1) accounts for high affinity glutamate uptake into adult rodent nerve endings
  58. Noxious Stimulation Induces Trk Receptor and Downstream ERK Phosphorylation in Spinal Dorsal Horn
  59. Cyclothiazide Unmasks an AMPA-Evoked Release of Arachidonic Acid from Cultured Striatal Neurones
  60. Glucose Regulates Glutamate-Evoked Arachidonic Acid Release from Cultured Striatal Neurons
  61. Hydrogen Peroxide Enhances Signal-Responsive Arachidonic Acid Release from Neurons: Role of Mitogen-Activated Protein Kinase
  62. MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide
  63. Phosphatidylinositol 3‐kinase is a central mediator of NMDA receptor signalling to MAP kinase (Erk1/2), Akt/PKB and CREB in striatal neurones
  64. Hydrogen peroxide‐mediated phosphorylation of ERK1/2, 
Akt/PKB and JNK in cortical neurones: dependence 
on Ca2+ and PI3‐kinase
  65. Contrasting influences of glucuronidation and O -methylation of epicatechin on hydrogen peroxide-induced cell death in neurons and fibroblasts
  66. Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein
  67. Genes encoding multiple forms of phospholipase A2 are expressed in rat brain
  68. Reduction of gaba and glutamate transporter messenger rnas in the severe-seizure genetically epilepsy-prone rat
  69. Ethanol modulates N-methyl-d-aspartate-evoked arachidonic acid release from neurones
  70. Reduced glucose metabolism enhances the glutamate-evoked release of arachidonic acid from striatal neurons
  71. Effects of acute and chronic ethanol on cyclic AMP accumulation in NG108-15 cells: differential dependence of changes on extracellular adenosine
  72. Inhibition of ADP-ribosyltransferase increases synthesis of Gsα in neuroblastoma × glioma hybrid cells and reverses iloprost-dependent heterologous loss of fluoride-sensitive adenylate cyclase
  73. Gsα-dependent and -independent desensitisation of prostanoid IP receptor-activated adenylyl cyclase in NG108-15 cells
  74. Chronic Ethanol Reduces Immunologically Detectable Gqα/11α in NG108–15 Cells
  75. Binding sites for LH in Candida albicans: comparison with the mammalian corpus luteum LH receptor
  76. Characterization of a factor(s) from partially purified human gonadotrophin preparations which inhibit(s) the binding of radiolabelled human LH and human chorionic gonadotrophin to Candida albicans
  77. Receptor-mediated elevation of adenylate cyclase by luteinizing hormone in Candida albicans
  78. Specific, high-affinity binding sites for human luteinizing hormone (hLH) and human chorionic gonadotrophin (hCG) in candida species
  79. Measurement of Adenylyl Cyclase Activity in Cell Membranes